Search for: "Sanofi-Aventis v. Apotex"
Results 81 - 92
of 92
Sort by Relevance
|
Sort by Date
3 Oct 2007, 10:00 pm
The issue is not unique to the pharmaceutical industry, but the pressure is a little more acute because of the absolute monopoly in the product enjoyed by the innovator company just prior to the first generic launch.In some jurisdictions, most notably the UK, a line of authorities has sprung up which requires the generic company to either obtain a declaration of non-infringement or revoke the patent prior to launch.In the ongoing global Plavix litigation, the Australian Federal Court recently… [read post]
6 Aug 2007, 8:38 pm
Mylan Eloxatin: Sanofi-Aventis v. [read post]
2 Jul 2007, 2:51 pm
Apotex Ambien CR: Sanofi-Aventis v. [read post]
19 Jun 2007, 9:45 pm
By Donald Zuhn -- Sanofi-Aventis and Bristol-Myers Squibb announced today (June 19, 2007) that the U.S. [read post]
19 Jun 2007, 8:21 am
Sanofi-Synthelabo et al. v. [read post]
26 May 2007, 11:26 pm
District Judge Sid ney Stein in Manhattan could make a decision any day.Spokesmen for Bristol-Myers, Sanofi and Apotex all declined to comment. [read post]
6 May 2007, 9:06 pm
Ambien CR: Sanofi-Aventis v. [read post]
2 Apr 2007, 9:52 pm
Exela Pharmsci Ambien CR: Sanofi-Aventis v. [read post]
26 Jan 2007, 6:09 am
In August 2006, generic drug maker Apotex Inc. began selling a cheaper version of Plavix, a blood thinner Bristol-Myers co-markets with Sanofi-Aventis SA, after an agreement to settle a patent dispute fell apart. [read post]
21 Jan 2007, 10:48 am
IPBiz wonder how all the "patent reformers" pontificating about KSR v. [read post]
31 Aug 2006, 6:15 pm
See earlier posts from the Patent Baristas: Update: Sanofi and Bristol-Myers File for Preliminary Injunction Against Apotex Apotex To Launch Generic Plavix At Its Own Risk FTC Rejects Patent Deal by Bristol-Myers and Sanofi Does Sanofi-Aventis Patent Settlement With Apotex Reveal a Trend? [read post]
15 Aug 2006, 6:45 am
This is the court hearing the patent infringement suit, Sanofi-Synthelabo v. [read post]
